{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T11:40:30Z","timestamp":1778758830411,"version":"3.51.4"},"reference-count":61,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":154,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"name":"UCSD Clinical and Translational Research Institute (CTRI)"},{"DOI":"10.13039\/100000874","name":"Brain and Behavior Research Foundation (NARSAD)","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000874","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH","award":["MH042228"],"award-info":[{"award-number":["MH042228"]}]},{"name":"NIH","award":["MH042228"],"award-info":[{"award-number":["MH042228"]}]},{"name":"UCSD Clinical and Translational Research Institute"},{"DOI":"10.13039\/100000874","name":"Brain and Behavior Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000874","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Depress Anxiety"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1002\/da.22362","type":"journal-article","created":{"date-parts":[[2015,4,2]],"date-time":"2015-04-02T18:50:28Z","timestamp":1428000628000},"page":"400-407","source":"Crossref","is-referenced-by-count":41,"title":["INTRANASAL OXYTOCIN ADMINISTRATION PRIOR TO EXPOSURE THERAPY FOR ARACHNOPHOBIA IMPEDES TREATMENT RESPONSE"],"prefix":"10.1155","volume":"32","author":[{"given":"Dean T.","family":"Acheson","sequence":"first","affiliation":[{"name":"Department of Psychiatry; University of California; San Diego, La Jolla San Diego California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Feifel","sequence":"additional","affiliation":[{"name":"Department of Psychiatry; University of California; San Diego, La Jolla San Diego California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Kamenski","sequence":"additional","affiliation":[{"name":"Department of Psychiatry; University of California; San Diego, La Jolla San Diego California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Mckinney","sequence":"additional","affiliation":[{"name":"Department of Psychiatry; University of California; San Diego, La Jolla San Diego California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria B.","family":"Risbrough","sequence":"additional","affiliation":[{"name":"Department of Psychiatry; University of California; San Diego, La Jolla San Diego California"},{"name":"Center for Excellence in Stress and Mental Health; VA San Diego Healthcare System"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,3,31]]},"reference":[{"key":"10.1002\/da.22362-BIB0001|da22362-cit-0001","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.biopsych.2007.08.017","article-title":"Neuroplasticity as a target for the pharmacotherapy of psychiatric disorders: new opportunities for synergy with psychotherapy","volume":"62","author":"Krystal","year":"2007","journal-title":"Biol Psychiat"},{"key":"10.1002\/da.22362-BIB0002|da22362-cit-0002","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1037\/0735-7044.117.2.341","article-title":"Effects of D-cycloserine on extinction of conditioned freezing","volume":"117","author":"Ledgerwood","year":"2003","journal-title":"Behav Neurosci"},{"key":"10.1002\/da.22362-BIB0003|da22362-cit-0003","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1523\/JNEUROSCI.22-06-02343.2002","article-title":"Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of d-cycloserine as assessed with fear-potentiated startle in rats","volume":"22","author":"Walker","year":"2002","journal-title":"J Neurosci"},{"key":"10.1002\/da.22362-BIB0004|da22362-cit-0004","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1001\/archpsyc.61.11.1136","article-title":"Cognitive enhancers as adjuncts to psychotherapy","volume":"61","author":"Ressler","year":"2004","journal-title":"Arch Gen Psychiat"},{"key":"10.1002\/da.22362-BIB0005|da22362-cit-0005","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.biopsych.2008.01.012","article-title":"A meta-analysis of d-cycloserine and the facilitation of fear extinction and exposure therapy","volume":"63","author":"Norberg","year":"2008","journal-title":"Biol Psychiat"},{"key":"10.1002\/da.22362-BIB0006|da22362-cit-0006","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1176\/appi.ajp.2014.13121625","article-title":"A randomized, double-blind evaluation of d-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans","volume":"171","author":"Rothbaum","year":"2014","journal-title":"Am J Psychiatry"},{"key":"10.1002\/da.22362-BIB0007|da22362-cit-0007","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1601-183X.2012.00801.x","article-title":"Fear extinction and BDNF: translating animal models of PTSD to the clinic","volume":"11","author":"Andero","year":"2012","journal-title":"Genes Brain Behav"},{"key":"10.1002\/da.22362-BIB0008|da22362-cit-0008","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00213-011-2353-x","article-title":"Effect of d-cycloserine and valproic acid on the extinction of reinstated fear-conditioned responses and habituation of fear conditioning in healthy humans: a randomized controlled trial","volume":"218","author":"Kuriyama","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1002\/da.22362-BIB0009|da22362-cit-0009","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.neuropharm.2012.06.063","article-title":"Cannabinoid facilitation of fear extinction memory recall in humans","volume":"64","author":"Rabinak","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1002\/da.22362-BIB0010|da22362-cit-0010","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1017\/S109285290000047X","article-title":"A psychobiological rationale for oxytocin in the treatment of posttraumatic stress disorder","volume":"15","author":"Olff","year":"2010","journal-title":"CNS Spectrum"},{"key":"10.1002\/da.22362-BIB0011|da22362-cit-0011","doi-asserted-by":"crossref","first-page":"6607","DOI":"10.1523\/JNEUROSCI.4572-07.2008","article-title":"Oxytocin attenuates affective evaluations of conditioned faces and amygdala activity","volume":"28","author":"Petrovic","year":"2008","journal-title":"J Neurosci"},{"key":"10.1002\/da.22362-BIB0012|da22362-cit-0012","first-page":"1","article-title":"Oxytocin enhances resting-state connectivity between amygdala and medial frontal cortex","volume":"30","author":"Sripada","year":"2012","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1002\/da.22362-BIB0013|da22362-cit-0013","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.psyneuen.2014.03.009","article-title":"Oxytocin in the prelimbic medial prefrontal cortex reduces anxiety-like behavior in female and male rats","volume":"45","author":"Sabihi","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"10.1002\/da.22362-BIB0014|da22362-cit-0014","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1016\/j.psyneuen.2013.04.006","article-title":"Oxytocinergic manipulations in corticolimbic circuit differentially affect fear acquisition and extinction","volume":"38","author":"Lahoud","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1002\/da.22362-BIB0015|da22362-cit-0015","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00213-013-3099-4","article-title":"The effect of intranasal oxytocin treatment on conditioned fear extinction and recall in a healthy human sample","volume":"229","author":"Acheson","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1002\/da.22362-BIB0016|da22362-cit-0016","article-title":"Oxytocin facilitates the extinction of conditioned fear in humans","author":"Eckstein","journal-title":"Biol Psychiat"},{"key":"10.1002\/da.22362-BIB0017|da22362-cit-0017","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00213-012-2702-4","article-title":"Central administration of oxytocin receptor ligands affects cued fear extinction in rats and mice in a timepoint-dependent manner","volume":"223","author":"Toth","year":"2012","journal-title":"Psychopharmacology"},{"key":"10.1002\/da.22362-BIB0018|da22362-cit-0018","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1016\/j.psyneuen.2013.04.006","article-title":"Oxytocinergic manipulations in corticolimbic circuit differentially affect fear acquisition and extinction","volume":"38","author":"Lahoud","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1002\/da.22362-BIB0019|da22362-cit-0019","doi-asserted-by":"crossref","first-page":"18144","DOI":"10.1073\/pnas.1208852109","article-title":"Oxytocin facilitates protective responses to aversive social stimuli in males","volume":"109","author":"Striepens","year":"2012","journal-title":"Proc Natl Acad Sci"},{"key":"10.1002\/da.22362-BIB0020|da22362-cit-0020","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/mp.2012.156","article-title":"Oxytocin increases anxiety to unpredictable threat","volume":"18","author":"Grillon","year":"2013","journal-title":"Mol Psychiatr"},{"key":"10.1002\/da.22362-BIB0021|da22362-cit-0021","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S1077-7229(03)80005-6","article-title":"Beyond the manual: the insider's guide to prolonged exposure therapy for PTSD","volume":"10","author":"Hembree","year":"2003","journal-title":"Cogn Behav Practice"},{"key":"10.1002\/da.22362-BIB0022|da22362-cit-0022","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1037\/0022-006X.72.3.411","article-title":"Therapeutic alliance, negative mood regulation, and treatment outcome in child abuse-related posttraumatic stress disorder","volume":"72","author":"Cloitre","year":"2004","journal-title":"J Consult Clin Psych"},{"key":"10.1002\/da.22362-BIB0023|da22362-cit-0023","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1038\/npp.2014.156","article-title":"Brain oxytocin in social fear conditioning and its extinction: involvement of the lateral septum","volume":"39","author":"Zoicas","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1002\/da.22362-BIB0024|da22362-cit-0024","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1007\/s00213-013-3356-6","article-title":"Role of oxytocin receptors in modulation of fear by social memory","volume":"231","author":"Guzman","year":"2014","journal-title":"Pyschopharmacology"},{"key":"10.1002\/da.22362-BIB0025|da22362-cit-0025","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1038\/npp.2011.95","article-title":"The neuropeptide oxytocin facilitates pro-social behavior and prevents social avoidance in rats and mice","volume":"36","author":"Lukas","year":"2011","journal-title":"Neruopsychopharmacology"},{"key":"10.1002\/da.22362-BIB0026|da22362-cit-0026","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/0091-3057(92)90418-F","article-title":"Enhanced social interactions in rats following chronic, centrally infused oxytocin","volume":"43","author":"Witt","year":"1992","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1002\/da.22362-BIB0027|da22362-cit-0027","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.neuron.2008.04.009","article-title":"Oxytocin shapes the neural circuitry of trust and trust adaptation in humans","volume":"58","author":"Baumgartner","year":"2008","journal-title":"Neuron"},{"key":"10.1002\/da.22362-BIB0028|da22362-cit-0028","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nature03701","article-title":"Oxytocin increases trust in humans","volume":"435","author":"Kosfeld","year":"2005","journal-title":"Nature"},{"key":"10.1002\/da.22362-BIB0029|da22362-cit-0029","first-page":"301","article-title":"Social effects of oxytocin in humans: context and person matter","volume":"15","author":"Bartz","year":"2011","journal-title":"Trends Cogn Sci"},{"key":"10.1002\/da.22362-BIB0030|da22362-cit-0030","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1177\/0269881111400642","article-title":"Anxiolytic-like effect of oxytocin in the simulated public speaking test","volume":"26","author":"Oliveira","year":"2012","journal-title":"J Psychopharmacol"},{"key":"10.1002\/da.22362-BIB0031|da22362-cit-0031","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1038\/npp.2010.123","article-title":"Oxytocin attenuates amygdala reactivity to fear in generalized social anxiety disorder","volume":"35","author":"Labuschagne","year":"2010","journal-title":"Neuropsychopharacology"},{"key":"10.1002\/da.22362-BIB0032|da22362-cit-0032","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1037\/0022-006X.67.4.599","article-title":"The effects of changing contexts on return of fear following exposure therapy for spider fear","volume":"67","author":"Mineka","year":"1999","journal-title":"J Consult Clin Psych"},{"key":"10.1002\/da.22362-BIB0033|da22362-cit-0033","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1037\/0022-006X.59.3.425","article-title":"Opioid antagonist impedes exposure","volume":"59","author":"Merluzzi","year":"1991","journal-title":"J Consult Clin Psych"},{"key":"10.1002\/da.22362-BIB0034|da22362-cit-0034","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1037\/0022-006X.71.2.243","article-title":"Changes in caffeine states enhance return of fear in spider phobia","volume":"71","author":"Mystkowski","year":"2003","journal-title":"J Consult Clin Psychol"},{"key":"10.1002\/da.22362-BIB0035|da22362-cit-0035","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0005-7894(74)80008-0","article-title":"Psychometric description of some specific-fear questionnaires","volume":"5","author":"Klorman","year":"1974","journal-title":"Behav Ther"},{"key":"10.1002\/da.22362-BIB0036|da22362-cit-0036","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0005-7916(94)00072-T","article-title":"Fear of spiders questionnaire","volume":"26","author":"Szymanski","year":"1995","journal-title":"J Behav Ther Exp Psy"},{"key":"10.1002\/da.22362-BIB0037|da22362-cit-0037","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0005-7967(71)90015-5","article-title":"The comparison of two different methods of assessing fear and avoidance behavior","volume":"9","author":"Borkovec","year":"1971","journal-title":"Behav Res Ther"},{"key":"10.1002\/da.22362-BIB0038|da22362-cit-0038","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1037\/0022-006X.61.5.865","article-title":"Opioid antagonist affects behavioral effects of exposure in vivo","volume":"6","author":"Arntz","year":"1993","journal-title":"J Consult Clin Psychol"},{"key":"10.1002\/da.22362-BIB0039|da22362-cit-0039","volume-title":"Assessment Manual for Psychopharmacology","author":"Guy","year":"1976"},{"key":"10.1002\/da.22362-BIB0040|da22362-cit-0040","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/10503300500352500","article-title":"Development and validation of a revised short version of the Working Alliance Inventory","volume":"16","author":"Hatcher","year":"2006","journal-title":"Psychother Res"},{"key":"10.1002\/da.22362-BIB0041|da22362-cit-0041","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0005-7916(72)90045-6","article-title":"Credibility of analogue therapy rationales","volume":"3","author":"Borkovec","year":"1972","journal-title":"J Behav Ther Exp Psychiatry"},{"key":"10.1002\/da.22362-BIB0042|da22362-cit-0042","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1038\/npp.2012.71","article-title":"Oxytocin and the social brain: beware the complexity","volume":"37","author":"Bartels","year":"2012","journal-title":"Neuropyschopharmacology"},{"key":"10.1002\/da.22362-BIB0043|da22362-cit-0043","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.yhbeh.2011.12.009","article-title":"Oxytocin modulates cooperation within and competition between groups: an integrative review and research agenda","volume":"61","author":"Dreu","year":"2012","journal-title":"Horm Behav"},{"key":"10.1002\/da.22362-BIB0044|da22362-cit-0044","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.1002\/hbm.22508","article-title":"Oxytocin facilitates the sensation of social stress","volume":"35","author":"Eckstein","year":"2014","journal-title":"Hum Brain Mapp"},{"key":"10.1002\/da.22362-BIB0045|da22362-cit-0045","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.psyneuen.2010.07.004","article-title":"Oxytocin indexes relational distress following interpersonal harms in women","volume":"36","author":"Tabak","year":"2011","journal-title":"Psychoneuroendocrinology"},{"key":"10.1002\/da.22362-BIB0046|da22362-cit-0046","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1471-244X-14-92","article-title":"Efficacy of oxytocin administration early after psychotrauma in preventing the development of PTSD: study protocol of a randomized controlled trial","volume":"14","author":"Frijling","year":"2014","journal-title":"BMC Psychiatry"},{"key":"10.1002\/da.22362-BIB0047|da22362-cit-0047","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/nn.3465","article-title":"Fear-enhancing effects of septal oxytocin receptors","volume":"16","author":"Guzman","year":"2013","journal-title":"Nat Neurosci"},{"key":"10.1002\/da.22362-BIB0048|da22362-cit-0048","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/0031-9384(78)90309-8","article-title":"Opposite action of oxytocin to vasopressin in passive avoidance behavior in rats","volume":"20","author":"Kovacs","year":"1978","journal-title":"Physiol Behav"},{"key":"10.1002\/da.22362-BIB0049|da22362-cit-0049","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0006-8993(79)91009-6","article-title":"Effect of oxytocin and vasopressin on memory consolidation: sites of action and catecholaminergic correlates after local microinjection into limbic-midbrain structures","volume":"175","author":"Kovacs","year":"1979","journal-title":"Brain Res"},{"key":"10.1002\/da.22362-BIB0050|da22362-cit-0050","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1073\/pnas.88.4.1494","article-title":"Interactive effects of neurohypophyseal neuropeptides with receptor antagonists on passive avoidance behavior: mediation by a cerebral neurohypophyseal hormone receptor?","volume":"88","author":"Wied","year":"1991","journal-title":"Proc Natl Acad Sci"},{"key":"10.1002\/da.22362-BIB0051|da22362-cit-0051","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.psyneuen.2009.01.005","article-title":"A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorder","volume":"34","author":"Guastella","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"10.1002\/da.22362-BIB0052|da22362-cit-0052","volume-title":"Diagnostic and statistical manual of mental disorders","year":"2014"},{"key":"10.1002\/da.22362-BIB0053|da22362-cit-0053","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnins.2013.00035","article-title":"Helping oxytocin deliver: considerations in the development of oxytocin-based therapeutics for brain disorders","volume":"7","author":"MacDonald","year":"2013","journal-title":"Front Neurosci"},{"key":"10.1002\/da.22362-BIB0054|da22362-cit-0054","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.psyneuen.2009.06.016","article-title":"Effects of intranasal oxytocin on emotional face processing in women","volume":"35","author":"Domes","year":"2010","journal-title":"Psychoneuroendocrinology"},{"key":"10.1002\/da.22362-BIB0055|da22362-cit-0055","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.biopsych.2007.03.025","article-title":"Oxytocin attenuates amygdala responses to emotional faces regardless of valence","volume":"62","author":"Domes","year":"2007","journal-title":"Biol Psychiat"},{"key":"10.1002\/da.22362-BIB0056|da22362-cit-0056","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.biopsych.2010.04.039","article-title":"Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients","volume":"68","author":"Feifel","year":"2010","journal-title":"Biol Psychiat"},{"key":"10.1002\/da.22362-BIB0057|da22362-cit-0057","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jpsychires.2006.05.006","article-title":"A randomized controlled trial of the effect of D-cycloserine on exposure therapy for spider fear","volume":"41","author":"Guastella","year":"2007","journal-title":"J Psychiatr Res"},{"key":"10.1002\/da.22362-BIB0058|da22362-cit-0058","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.yhbeh.2011.12.003","article-title":"Modulating social behavior with oxytocin: how does it work? What does it mean?","volume":"61","author":"Churchland","year":"2012","journal-title":"Horm Behav"},{"key":"10.1002\/da.22362-BIB0059|da22362-cit-0059","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1016\/j.psyneuen.2013.03.003","article-title":"Increased brain and plasma oxytocin after nasal and peripheral administration in rats and mice","volume":"38","author":"Neumann","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1002\/da.22362-BIB0060|da22362-cit-0060","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nn0602-849","article-title":"Sniffing neuropeptides: a transnasal approach to the human brain","volume":"5","author":"Born","year":"2002","journal-title":"Nat Neurosci"},{"key":"10.1002\/da.22362-BIB0061|da22362-cit-0061","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2826.2012.02303.x","article-title":"Oxytocin and vasopressin agonists and antagonists as research tools and potential therapeutics","volume":"24","author":"Manning","year":"2012","journal-title":"J Neuroendocrinol"}],"container-title":["Depression and Anxiety"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fda.22362","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fda.22362","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/da.22362\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T13:03:50Z","timestamp":1671541430000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/da.22362"}},"subtitle":["Research Article: Intranasal Oxytocin Administration"],"short-title":[],"issued":{"date-parts":[[2015,3,31]]},"references-count":61,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"URL":"https:\/\/doi.org\/10.1002\/da.22362","archive":["Portico"],"relation":{},"ISSN":["1091-4269"],"issn-type":[{"value":"1091-4269","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3,31]]}}}